Categories: DiagnosticsDNANews

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

SALT LAKE CITY, Oct. 30, 2025 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host a virtual fireside chat on Wednesday, November 5, 2025 at 11:00 am ET.

Join Dwight Egan, CEO of Co-Dx, for an update on the Company’s growth initiatives, including its recently announced definitive agreement with Arabian Eagle in the Kingdom of Saudi Arabia to form CoMira Diagnostics and to advance the regional deployment of the Co-Dx™ PCR platform* across the Middle East.

Virtual Fireside Chat Details

A Q&A session will take place at the end of the discussion, and a recording of the fireside chat will be available on Co-Dx’s Investor Relations website following the event. To ensure your questions are addressed, please submit them in advance to CODX@kcsa.com.

*The Co-Dx PCR platform (including the PCR Home™, PCR Pro™, mobile app, and all associated tests) is subject to review by the FDA and/or other regulatory bodies and is not currently available for sale.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-to-host-fireside-chat-on-november-5th-with-ceo-dwight-egan-to-discuss-recently-announced-definitive-agreement-in-saudi-arabia-302600199.html

SOURCE Co-Diagnostics

Staff

Recent Posts

Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe

COPENHAGEN, Denmark, Jan. 15, 2026 /PRNewswire/ -- The Novo Nordisk Foundation has allocated up to DKK…

1 hour ago

RETRANSMISSION: Who Is the Best Facelift Surgeon in the U.S.?

The Best Facelift Surgeon in the U.S. is Dr. Santos SEATTLE, WASHINGTON / ACCESS Newswire…

1 hour ago

A True Empowerer – AGFA HealthCare Radiates Imaging Innovation at ECR 2026

In Vienna, Enterprise Imaging offers the "Clinician-First" approach to keeping radiologists in their flow, spotlighting…

4 hours ago

EDETEK Launches “Ensemble” AI Managed Services to Simplify Adoption of AI and Accelerate Clinical Development

Orchestrated AI delivered as a service for measurable impactPRINCETON, N.J., Jan. 14, 2026 /PRNewswire/ -- EDETEK…

13 hours ago

MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026

Medical AI Made Easy—From Lab to Real-World Training & Practical Use CHEROKEE, Texas, Jan. 14,…

13 hours ago

Amsive Announces Amsive Health, Formalizing Its Healthcare Marketing Practice to Drive Accelerated Growth for Health Plans, Health Systems, and Providers

Built on decades of healthcare experience, trusted by the nation's leading brands, and powered by…

13 hours ago